Danne Thomas, von Schütz Wolfgang, Lange Karin, Nestoris Claudia, Datz Nicolin, Kordonouri Olga
Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz-Korczak-Allee, Hannover, Germany.
Pediatr Diabetes. 2006 Aug;7 Suppl 4:25-31. doi: 10.1111/j.1399-543X.2006.00166.x.
Increasing evidence points to the importance of achieving low blood glucose variability and also a low hemoglobin A1c (HbA1c) to prevent diabetic late complications. Continuous subcutaneous insulin infusion (CSII) is associated with lower blood glucose variability in children. Frequent indications for starting CSII in youth are recurrent hypoglycemia, need for increased flexibility, poor glycemic control, dawn phenomenon, or needle phobia. At our center, about one-third of all patients across all age groups are currently on CSII. Although the average glycemic control is not very different from those on multiple daily injections, fewer patients are seen in the segment of very high and very low HbA1c with CSII. Across centers, the 'recipes' tailoring CSII treatment to individual patients and cultures are based more on experience than on evidence. However, several typical pediatric features have been identified. Patterns of the hourly basal rate and prandial insulin requirements vary with age. While many adolescents have increased requirements at dawn and dusk, young children show increasing needs in the second half of the day. Low insulin requirements, particularly in neonates, may need insulin dilution. The selection of catheters and needles has to be appropriate for the age. The opportunity to have an electronic memory read-out of all entries and alarms offers new possibilities of therapeutic monitoring, particularly in those youth not keeping good logbooks. This feature can be helpful, if a trustful relationship between the diabetes team and the family is established.
越来越多的证据表明,实现低血糖变异性以及低糖化血红蛋白(HbA1c)对于预防糖尿病晚期并发症至关重要。持续皮下胰岛素输注(CSII)与儿童较低的血糖变异性相关。青少年开始使用CSII的常见指征包括反复低血糖、需要增加灵活性、血糖控制不佳、黎明现象或针头恐惧症。在我们中心,目前所有年龄组的患者中约有三分之一正在接受CSII治疗。尽管平均血糖控制与接受多次每日注射的患者没有太大差异,但接受CSII治疗的患者中糖化血红蛋白水平极高和极低的比例较低。在各个中心,根据个体患者和文化情况调整CSII治疗的“方法”更多是基于经验而非证据。然而,已经确定了一些典型的儿科特征。每小时基础率和餐时胰岛素需求量的模式随年龄而变化。许多青少年在黎明和黄昏时需求增加,而幼儿在一天的后半段需求增加。胰岛素需求量低,尤其是新生儿,可能需要稀释胰岛素。导管和针头的选择必须适合年龄。能够通过电子方式读取所有记录和警报为治疗监测提供了新的可能性,特别是对于那些没有好好记录日志的青少年。如果糖尿病团队与家庭之间建立了信任关系,这一功能会很有帮助。